Clinical Trials · NCT02274740
Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Sanofi
- Enrollment
- 2
- Start date
- Apr 2015
- Locations
- See registry
- Primary endpoint
- Change in plasma triglycerides after 10 weeks of treatment area under-the-time concentration curve between 0 and 480 minutes (AUC0-480 min)